Search Results - "Rico, Maria J."

Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment by Croci, Diego O, Zacarías Fluck, Mariano F, Rico, María J, Matar, Pablo, Rabinovich, Gabriel A, Scharovsky, O Graciela

“…Accumulating evidence indicates that a dynamic cross-talk between tumors and the immune system can regulate tumor growth and metastasis. Increased…”
Get full text

Paclitaxel delivery system based on poly(lactide‐co‐glycolide) microparticles and chitosan thermo‐sensitive gel for mammary adenocarcinoma treatment by Pesoa, Juan I., Rico, María J., Rozados, Viviana R., Scharovsky, O. Graciela, Luna, Julio A., Mengatto, Luciano N.

“…Objectives To evaluate the combination of more than one release system in the same formulation as a useful strategy to achieve paclitaxel delivery in a more…”
Get full text

Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model by Zacarías Fluck, Mariano F, Rico, María J, Gervasoni, Silvia I, Ilarregui, Juan M, Toscano, Marta A, Rabinovich, Gabriel A, Scharovsky, O Graciela

“…In recent years, one of the most important insights into tumor immunity was provided by the identification of negative regulatory pathways and immune escape…”
Get full text

Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy by Perroud, Herman A, Alasino, Carlos M, Rico, Maria J, Queralt, Francisco, Pezzotto, Stella M, Rozados, Viviana R, Scharovsky, O Graciela

“…The objective of the study was to detect changes in quality of life (QoL) in metastatic breast cancer patients treated with metronomic chemotherapy with daily…”
Get full text

Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay by Rico, María J., Perroud, Herman A., Herrera, Cintia, Alasino, Carlos M., Roggero, Eduardo A., Pezzotto, Stella M., Nocito, Ana Lía, Rozados, Viviana R., Scharovsky, O. Graciela

“…Identifying tumor biomarkers associated with clinical behavior in breast cancer patients may allow higher accuracy in the selection of treatment. Different…”
Get full text

Antitumor activity of new chemical compounds in triple negative mammary adenocarcinoma models by Giolito, María V, Camacho, Cristian M, Martinez-Amezaga, Maitena, Traficante, Carla I, Giordano, Rocío A, Cornier, Patricia G, Mata, Ernesto G, Delpiccolo, Carina Ml, Boggián, Dora B, Giúdice, Antonela Del, Mainetti, Leandro E, Scharovsky, Olga G, Rozados, Viviana R, Rico, María J

“…According to the need for the development of new anticancer agents, we have synthetized novel bioactive compounds and aimed to determine their antitumor…”
Get full text

The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide by Rozados, Viviana R, Mainetti, Leandro E, Rico, María J, Zacarías Fluck, Mariano F, Matar, Pablo, Scharovsky, O Graciela

“…Metronomic chemotherapy (MCT) is a novel therapeutic strategy for cancer treatment endowed with an antiangiogenic effect. It refers to regular administration…”
Get more information

Modulation of IL-10/IL-10R expression by mafosfamide, a derivative of 4-hydroxycyclophosphamide, in a rat B-cell lymphoma by Rico, Maria J, Matar, Pablo, Scharovsky, O Graciela

“…We have already shown that IL-10 plays an important role in immunosuppression and metastatic dissemination in the rat B-cell lymphoma L-TACB model. It was…”
Get full text

Immunomodulation and antiangiogenesis in cancer therapy. From basic to clinical research by Scharovsky, O Graciela, Matar, Pablo, Rozados, Viviana R, Rico, María J, Zacarías Fluck, Mariano F, Mainetti, Leandro E, Fernández Zenóbi, M Virginia, Roggero, Eduardo A, Gervasoni, Silvia I, Rossa, Ana, Perroud, Hernán A, Sánchez, Andrea M, Celoria, Guillermo C, Font, María T

“…Basic and pre-clinic research in cellular and molecular oncology are the main supports accounting for the advancement in cancer therapeutics. The findings…”
Get full text

Abstract 3: Metronomic chemotherapy with cyclophosphamide (Cy) and the repositioned drug losartan (Los) for the treatment of M-234p triple negative murine mammary adenocarcinoma by Guercetti, Julian, Mainetti, Leandro E., Grillo, M.Carolina, Del Giúdice, Antonela, Baglioni, Maria V., Cáceres, Juan M., Arboatti, Ainelén, Francés, Daniel, Rozados, Viviana R., Rico, Maria J., Scharovsky, O.Graciela

“…Abstract Metronomic chemotherapy (MCT) refers to the chronic, equally spaced, delivery of low doses of chemotherapeutic drugs, without extended interruptions…”
Get full text

Abstract 4665: VEGF/SVEGFR-2 and VEGF/TSP-1 ratios as probable predictors of response to metronomic chemotherapy with Cyclophosphamide and Celecoxib in advanced breast cancer patients by Perroud, Herman A., Alasino, Carlos M., Rico, Maria J., Queralt, Francisco, Pezzotto, Stella M., Rozados, Viviana R., Scharovsky, O.Graciela

“…Abstract The efficacy and low toxicity of antiangiogenic metronomic chemotherapy (MCT) with cyclophosphamide (Cy) and celecoxib (Cel) in advanced breast cancer…”
Get full text

Abstract 1749: Phase I/II clinical trial: Metronomic chemotherapy with cyclophosphamide (Cy) and celecoxib (Cel) in breast cancer patients progressing after standard chemotherapy by Perroud, Herman A., Alasino, Carlos M., Rico, Maria J., Queralt, Francisco, Pezzotto, Stella M., Rozados, Viviana R., Scharovsky, O Graciela

“…Abstract Metronomic chemotherapy (MCT), the chronic administration at regular intervals of low doses of chemotherapeutic drugs without extended rest periods,…”
Get full text

Increased Osteoblastic and Osteocytic in Vitro Cell Viability by Yerba Mate (Ilex paraguariensis) by Villarreal, Laureana, Sanz, Natasha, Fagalde, Florencia Buiatti, D'Andrea, Florencia, Lombarte, Mercedes, Rico, María J, Rozados, Viviana R, Scharovsky, O Graciela, Plotkin, Lilian I, Di Loreto, Verónica E, Brun, Lucas R

“…Yerba mate (YM, Ilex paraguariensis) consumption beneficially affects the bones. However, whether YM components exert their effect on bone cells directly…”
Get full text

Abstract 2060: Metronomic chemotherapy (MCT): comparison of the efficacy of two combinations of drugs for the treatment of murine mammary adenocarcinomas by Rico, María J., Mainetti, Leandro E., Perroud, Herman A., Rozados, Viviana R., Scharovsky, O. Graciela

“…Abstract Metronomic chemotherapy (MCT) refers to the chronic, equally spaced, delivery of low doses of different chemotherapeutic drugs, without extended…”
Get full text

Abstract 795: Metronomic chemotherapy with cyclophosphamide and metformin inhibits tumor and metastasis growth M-406 murine mammary adenocarcinoma by Asad, Antonela S., Basualdo, Jesús, Micheletti, Lucía, Gardenal, María C. Capello, Perroud, Herman A., Rico, María J., Rozados, Viviana R., Scharovsky, O. Graciela

“…Abstract Metronomic chemotherapy (MCT) refers to the chronic, equally spaced, delivery of low doses of different chemotherapeutic drugs, without extended…”
Get full text

Abstract 5673: Mechanisms responsible for the antitumor effect of metronomic chemotherapy with cyclophosphamide (Cy) and doxorubicin (Dox) in murine tumor models of mammary adenocarcinoma by Mainetti, Leandro E., Rozados, Viviana R., Rico, María J., Roggero, Eduardo, Scharovsky, O. Graciela

“…Abstract Metronomic chemotherapy (MCT) refers to the chronic, equally spaced, delivery of low doses of different chemotherapeutic drugs, without extended…”
Get full text

Abstract 3552: Cancer immunoediting: Profile of cytokines in a mammary adenocarcinoma tumor model by Pagura, Lucas, Caceres, Juan M., Cardinale, Albertina, Scharovsky, Olga G., Di Masso, Ricardo J., Rico, María J., Rozados, Viviana R.

“…Abstract Cancer immunoediting is a dynamic process composed of three phases: elimination (EL), equilibrium (EQ), and escape (ES), that encompasses the…”
Get full text

Abstract 701: TUMOR lymphocyte infiltration, expression of CD4, CD8, FOXP3, CD34 molecules and their relationship with tumor evolution after primary treatment in breast cancer patients by Rico, María J., Rozados, Viviana R., Herrera, Cintia, Alasino, Carlos M., Roig, Laura M. Vargas, Gago, Francisco E., Tello, Olga, Nocito, Ana L., Roggero, Eduardo, Scharovsky, Olga G.

“…Abstract Considering that, approximately, only half of breast cancer patients respond to present therapies, a better knowledge of breast cancer biology, one of…”
Get full text

Abstract 3146: The involvement of Foxp3 or CD34 expression and tumor lymphocyte infiltration in the prognosis of breast carcinoma patients by Rico, María J., Rozados, Viviana R., Alasino, Carlos M., Roggero, Eduardo, Nocito, Ana L., Scharovsky, O Graciela

“…Abstract Breast cancer is a heterogeneous disease with different known biological subclasses some of which are associated with immune cell infiltration…”
Get full text

Abstract 2390: Growth analysis of M-406 mammary adenocarcinoma in F1 and F2 generations of a cross between resistant and susceptible mice lines by Cáceres, Juan M., Pagura, Lucas, Zacarías-Fluck, Mariano F., Scharovsky, O Graciela, Di Masso, Ricardo J., Rico, María J., Rozados, Viviana R.

“…Abstract Breast cancer is a complex, multifactor disease that affects about 10% of women in industrialized countries. Inbred mice models provide an interesting…”
Get full text